|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|---|
| ASSETS | |||||
| Current assets: | |||||
| Cash | |||||
| Prepaid expenses | |||||
| Total current assets | |||||
| Deferred offering costs | |||||
| Long-term prepaid insurance | |||||
| Investments held in Trust Account | |||||
| Total assets | |||||
| LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS’ DEFICIT | |||||
| Liabilities | |||||
| Current liabilities: | |||||
| Accrued expenses | |||||
| Accrued offering costs | |||||
| Accounts payable and accrued expenses | |||||
| Related party loan | |||||
| Total current liabilities | |||||
| Deferred legal fees | |||||
| Deferred advisory fee | |||||
| Deferred underwriting fee | |||||
| Total liabilities | |||||
| Temporary equity: | |||||
| Class A ordinary shares subject to possible redemption, 28,750,000 shares at redemption value of $10.32 per share at September 30, 2026 and $10.05 per share at December 31, 2025 | |||||
| Shareholders’ Deficit | |||||
| Ordinary shares, value | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total shareholders’ deficit | |||||
| Total liabilities, temporary equity and shareholders’ deficit |
Loading...